Telehealth providers may not know enough about a persons health to prescribe it safely
Why Use InBody
Health Canadas approval of Wegovy for chronic weight management in 2022, followed by the 2023 SELECT trial showing a 20% reduction in major adverse cardiovascular events [2], accelerated prescribing in both diabetes and obesity populations
Shima Hadidchi, MD , and her compassionate team in Victorville, CA, you are gaining a dedicated health advocate
0 mg, orlistat, phenterminetopiramate, and naltrexonebupropion for weight loss efficacy Semaglutide exerts its pharmacological activity by high-affinity, selective activation of the GLP-1 receptor on pancreatic ?-cells, ?-cells, and key appetite-regulating neuronal circuits: Pharmacokinetic Profile Route of Administration SC Dosing Frequency Once weekly Half-Life 184 hours Pharmacokinetic Profile: Route of Administration : Subcutaneous Dosing Frequency : Once weekly (subcutaneous) Half-Life : ~155184 hours (6.57.7 days), supporting once-weekly SC dosing Formulation : Formulation & Handling Reconstitute in sterile water or PBS (pH ~7.4) for in vivo/in vitro use Store at 20C in aliquots to prevent freeze-thaw degradation Shelf-stable for 12 months under recommended storage condition Clinical Trial Activity Clinical Trial Activity (Selected) References Quality & Purity This product is synthesized via solid-phase peptide synthesis (SPPS) and tested to 99% purity by HPLC with identity confirmed by mass spectrometry
DeBakey Veterans Affairs Medical Center (MEDVAMC) from January 2021 to December 2022
